BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2002
View Archived Issues
Positive preclinical results reported for Access's mucositis technology
Read More
Phase Ib study of BNP-166 successfully completed
Read More
Nastech demonstrates potential of nasal delivery of interferon beta-1a for treatment of MS
Read More
Oncolytics Biotech's phase I Reolysin study meets primary outcome
Read More
NIH licensing opportunity: plant-derived recombinant subunit vaccine candidate against HCV
Read More
Specific COX-2 inhibitor effective and safe for Rx of acute dental pain
Read More
Inosine demonstrates favorable results in toxicity tests
Read More
No dose adjustment required for LY-333531 in renally impaired patients
Read More
Milkhaus begins phase II trial of ML-04 as treatment of chronic prostatitis
Read More
Sequella Global Tuberculosis Foundation collaborates to develop new TB vaccines
Read More
PK/PD of OPC-51803 assessed in patients with urinary incontinence
Read More
Potent and selective antagonist of human Y5 receptor identified at Fujisawa
Read More
Roche licenses SEP from Gryphon Sciences
Read More
Cellegy submits NDS for Rectogesic approval in Canada
Read More
Zindaclin launched in the U.K. as once-daily acne treatment
Read More
Lipid formulation increases tissue distribution of the antifungal agent SPK-843
Read More
Thiazolidinedione derivative may have the potential to prevent chronic pancreatitis
Read More
The novel MMP inhibitor SI-27 exhibits antiangiogenic activity in vitro
Read More
Gilead seeks U.S. marketing approval of adefovir dipivoxil
Read More
PPARgamma agonists reported by Galderma in a recent patent
Read More
Takeda researchers identify new GnRH antagonists and their use
Read More
Dabur Research Foundation describes new substance P antagonists for the treatment of cancer
Read More
Novel group of integrin antagonists presented by 3-Dimensional Pharmaceuticals
Read More
Ono scientists present new CB2 receptor agonists
Read More
Mitsubishi Pharma discloses new compounds useful for Alzheimer's disease, ADHD, etc.
Read More